131 related articles for article (PubMed ID: 29429436)
21. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
23. Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
Spreafico F; Massimino M; Luksch R; Casanova M; Cefalo GS; Collini P; Ferrari A; Polastri D; Terenziani M; Gasparini M; Fossati-Bellani F
J Clin Oncol; 2002 Jun; 20(12):2783-8. PubMed ID: 12065554
[TBL] [Abstract][Full Text] [Related]
24. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol.
Todeschini G; Tecchio C; Degani D; Meneghini V; Marradi P; Balter R; Zanotti R; Ricetti M; Franchini M; Perona G
Ann Oncol; 1997; 8 Suppl 1():77-81. PubMed ID: 9187436
[TBL] [Abstract][Full Text] [Related]
25. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
Oriol A; Ribera JM; Bergua J; Giménez Mesa E; Grande C; Esteve J; Brunet S; Moreno MJ; Escoda L; Hernandez-Rivas JM; Hoelzer D
Cancer; 2008 Jul; 113(1):117-25. PubMed ID: 18457327
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Burkitt's lymphoma in Enugu, Nigeria.
Oguonu T; Emodi I; Kaine W
Ann Trop Paediatr; 2002 Dec; 22(4):369-74. PubMed ID: 12530287
[TBL] [Abstract][Full Text] [Related]
27. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.
Schwenn MR; Blattner SR; Lynch E; Weinstein HJ
J Clin Oncol; 1991 Jan; 9(1):133-8. PubMed ID: 1985162
[TBL] [Abstract][Full Text] [Related]
28. Determinants of survival in Nigerians with Burkitt's lymphoma.
Kagu MB; Durosinmi ; Adeodu OO; Akinola NO; Adediran IA; Salawu L
Afr J Med Med Sci; 2004 Sep; 33(3):195-200. PubMed ID: 15819463
[TBL] [Abstract][Full Text] [Related]
29. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy.
Kazembe P; Hesseling PB; Griffin BE; Lampert I; Wessels G
Med Pediatr Oncol; 2003 Jan; 40(1):23-5. PubMed ID: 12426682
[TBL] [Abstract][Full Text] [Related]
30. Burkitt lymphoma in South African children: one or two entities?
Stefan DC; Stones D; Newton R
Transfus Apher Sci; 2011 Apr; 44(2):191-4. PubMed ID: 21345736
[TBL] [Abstract][Full Text] [Related]
31. Treatment of Burkitt's lymphoma: the African experience.
Olweny CL; Nkrumah FK
IARC Sci Publ; 1985; (60):375-82. PubMed ID: 4065949
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Burkitt's lymphoma during pregnancy.
Lam MS
Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
[TBL] [Abstract][Full Text] [Related]
33. Pilot study of sodium phenylbutyrate as adjuvant in cyclophosphamide-resistant endemic Burkitt's lymphoma.
Phillips JA; Griffin BE
Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1265-9. PubMed ID: 17915270
[TBL] [Abstract][Full Text] [Related]
34. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Burkitt's lymphoma in Northwest Province, Cameroon, 2003-2010.
Lewis N; Young J; Hesseling PB; McCormick P; Wright N
Paediatr Int Child Health; 2012 May; 32(2):82-5. PubMed ID: 22595214
[TBL] [Abstract][Full Text] [Related]
36. Massive therapy and autologous bone marrow transplantation in very bad prognosis Burkitt's lymphoma.
Philip T; Biron P; Philip I; Favrot M; Souillet G; Philippe N; Hervé P; Plouvier E; Bernard JL; Raybaud C
IARC Sci Publ; 1985; (60):419-34. PubMed ID: 3905593
[TBL] [Abstract][Full Text] [Related]
37. [Intensive chemotherapy in Burkitt's lymphoma and aggressive non-Hodgkin's lymphoma].
Holte H; Smeland S; Blystad AK; Kvaløy S; Hammerstrøm J; Tjønnfjord GE
Tidsskr Nor Laegeforen; 2002 Feb; 122(4):364-9. PubMed ID: 11915663
[TBL] [Abstract][Full Text] [Related]
38. Burkitt's lymphoma in a 45-year-old Nigerian woman.
Lawal OO; Ojo OS; Durosinmi MA
Trop Geogr Med; 1990 Jul; 42(3):294-7. PubMed ID: 2293442
[TBL] [Abstract][Full Text] [Related]
39. [Acute kidney failure as the clinical presenting form of renal Burkitt's lymphoma in an HIV-positive patient].
Saurina A; Ramírez de Arellano M; Chiné M; Fulquet M; Lladó I; de las Cuevas X
Nefrologia; 2001; 21(6):601-5. PubMed ID: 11881432
[TBL] [Abstract][Full Text] [Related]
40. Burkitt's lymphoma in Kenya: geographical, age, gender and ethnic distribution.
Mwanda OW; Rochford R; Moormann AM; Macneil A; Whalen C; Wilson ML
East Afr Med J; 2004 Aug; (8 Suppl):S68-77. PubMed ID: 15622605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]